1. Home
  2. ROIV vs VFS Comparison

ROIV vs VFS Comparison

Compare ROIV & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • VFS
  • Stock Information
  • Founded
  • ROIV 2014
  • VFS 2017
  • Country
  • ROIV United Kingdom
  • VFS Vietnam
  • Employees
  • ROIV N/A
  • VFS N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • VFS Blank Checks
  • Sector
  • ROIV Health Care
  • VFS Finance
  • Exchange
  • ROIV Nasdaq
  • VFS Nasdaq
  • Market Cap
  • ROIV 7.8B
  • VFS 8.2B
  • IPO Year
  • ROIV N/A
  • VFS N/A
  • Fundamental
  • Price
  • ROIV $11.85
  • VFS $3.57
  • Analyst Decision
  • ROIV Buy
  • VFS Buy
  • Analyst Count
  • ROIV 3
  • VFS 3
  • Target Price
  • ROIV $15.25
  • VFS $5.75
  • AVG Volume (30 Days)
  • ROIV 4.6M
  • VFS 497.3K
  • Earning Date
  • ROIV 08-11-2025
  • VFS 09-19-2025
  • Dividend Yield
  • ROIV N/A
  • VFS N/A
  • EPS Growth
  • ROIV N/A
  • VFS N/A
  • EPS
  • ROIV N/A
  • VFS N/A
  • Revenue
  • ROIV $23,233,000.00
  • VFS $2,103,991,902.00
  • Revenue This Year
  • ROIV $3.28
  • VFS N/A
  • Revenue Next Year
  • ROIV $156.84
  • VFS $40.04
  • P/E Ratio
  • ROIV N/A
  • VFS N/A
  • Revenue Growth
  • ROIV N/A
  • VFS 65.72
  • 52 Week Low
  • ROIV $8.73
  • VFS $2.56
  • 52 Week High
  • ROIV $13.06
  • VFS $5.38
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 58.16
  • VFS 54.71
  • Support Level
  • ROIV $10.90
  • VFS $3.43
  • Resistance Level
  • ROIV $12.12
  • VFS $3.58
  • Average True Range (ATR)
  • ROIV 0.30
  • VFS 0.09
  • MACD
  • ROIV 0.03
  • VFS 0.01
  • Stochastic Oscillator
  • ROIV 77.87
  • VFS 93.10

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.

Share on Social Networks: